A partial list of articles in the peer-reviewed literature documenting adverse reactions after the vaccine. There are close to 500 articles here.
Note:
I didn’t compile this. Someone else did, but I don’t know who did because they didn’t put their name on the Word file presumably because they wanted to remain anonymous.
Neuro:
General Neuro side effects: https://onlinelibrary.wiley.com/doi/full/10.1111/ane.13451?fbclid=IwAR1CemFwLUpsMK19GMZa_xPF775Q4B0IiksbrziKUpIrRXhYR5cDQFFfVAQ
Small fiber neuropathy: https://onlinelibrary.wiley.com/doi/10.1002/mus.27251...
2 cases of Parsonage Turner Syndrome following Moderna and Pfizer: https://pubmed.ncbi.nlm.nih.gov/34402669/
Trigeminal Neuralgia and cervical radiculitis after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34155020/
Neuralgic amyotrophy following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34347105/
Amyotrophic neuralgia secondary to AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34330677/
36yoM with transverse myelitis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/33787891/
Acute Myelitis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34392078/
67yoF with transverse myelitis following Moderna 1st dose: https://pubmed.ncbi.nlm.nih.gov/34482455/
Longitudinal extensive transverse myelitis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34507942/
Transverse Myelitis and Bells Palsy after J&J vaccination: https://pubmed.ncbi.nlm.nih.gov/34458035/
Recurrent GBS following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34468703/
GBS following Johnson and Johnson: https://www.onlinescientificresearch.com/articles/the-development-of-guillain-barre-syndrome-subsequent-to-administration-of-ad26cov2s-vaccine.pdf
4 cases of GBS following Astra Zeneca:
https://pubmed.ncbi.nlm.nih.gov/34114269/
GBS following 2nd dose of Pfizer:: https://pubmed.ncbi.nlm.nih.gov/34347563/
GBS after the first dose of Pfizer: https://pubmed.ncbi.nlm.nih.gov/33758714/
GBS in a 25yoF following 2nd dose of Pfizer: https://pubmed.ncbi.nlm.nih.gov/34346014/
GBS in a 61yoM following Moderna: https://pubmed.ncbi.nlm.nih.gov/34484780/
GBS in a 65yoM liver transplant patient following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34431208/
GBS in a 73yoM following Moderna: https://pubmed.ncbi.nlm.nih.gov/34477091/
GBS in 73yoM following 2nd dose of Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253659/
GBS in 82yoF following 1st dose Pfizer: https://pubmed.ncbi.nlm.nih.gov/33758714/
GBS 10 days after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34272622/
GBS 11 days after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34187803/
GBS following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34330729/
7 cases of GBS following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34114256/
GBS following AstraZeneca with papilledema as atypical onset: https://pubmed.ncbi.nlm.nih.gov/34418708/
2 cases of Sensory GBS following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34416410/
Bilateral facial weakness with paresthesia variant of GBS following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34261746/
Bifacial diplegia variant of GBS following J&J vaccination: https://pubmed.ncbi.nlm.nih.gov/34449715/
Facial Weakness, extremity weakness, encephalopathy, and severe refractory ITP following Moderna: https://pubmed.ncbi.nlm.nih.gov/33854395/
Transient akathisia after Pfizer:
https://pubmed.ncbi.nlm.nih.gov/34113842/
Phantosmia: https://pubmed.ncbi.nlm.nih.gov/34096896/
21yoF nurse with Bells Palsy following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34322761/
34yoF with Bells Palsy 2 days after Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143982/
36yo with Bells Palsy, left arm tingling/numbness/weakness following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34336436/
37yoM with Bells Palsy after Pfizer: https://pubmed.ncbi.nlm.nih.gov/33611630/
50yoM with Bells Palsy after Pfizer, ongoing symptoms after 21 days: https://pubmed.ncbi.nlm.nih.gov/34330676/
57yoF with Bells Palsy <36 hours after 2nd dose of Pfizer: https://pubmed.ncbi.nlm.nih.gov/33594349/
61yoM with Bells Palsy after each dose of Pfizer: https://pubmed.ncbi.nlm.nih.gov/34281950/
Bells Palsy following mRNA and inactivated (CoronaVac) vaccines: a case series and nested case-control study: https://pubmed.ncbi.nlm.nih.gov/34411532/
Rate of Bells Palsy following mRNA vaccination is 2-3x higher then expected: https://pubmed.ncbi.nlm.nih.gov/34111409/
Neuromyelitis optica spectrum disorder (NMOSD): https://link.springer.com/article/10.1007/s10072-021-05427-4?fbclid=IwAR2DGcW8Y5UxvdzcOQaBUPn6_RTZGQRSsNo6bzanyAm9yN6387E3Z6WrKlI
Patient’s first MS Flare following Pfizer:
https://link.springer.com/article/10.1007/s00415-021-10648-w
4 cases of activation of stable MS, 2 cases of new MS, 1 case of new onset neuromyelitis optica after mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34480607/
Severe Multiple Sclerosis relapse after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34447349/
Optic neuritis and transverse myelitis in MS patient after Astrazeneca vaccination: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205198/
Myasthenia Gravis Flare Following Moderna: https://www.cureus.com/articles/60348-a-case-of-covid-19-vaccine-causing-a-myasthenia-gravis-crisis
CVA and Thrombocytopenia following Astrazeneca: https://pubmed.ncbi.nlm.nih.gov/34175640/
Central venous sinus thrombosis with subarachnoid hemorrhage in a 45yoM following Moderna: https://pubmed.ncbi.nlm.nih.gov/34478433/
Cerebral venous thrombosis and pulmonary embolus following AstraZeneca: https://www.sciencedirect.com/.../pii/S0196064421003425
Cerebral venous sinus thrombosis after AstraZeneca, neurologic and radiological management: https://pubmed.ncbi.nlm.nih.gov/34327553/
Cerebral venous sinus thrombosis, subarachnoid hemorrhage, and thrombocytopenia following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34485807/
Cerebral Venous sinus thrombosis, review of European cases: https://pubmed.ncbi.nlm.nih.gov/34293217/
Review of European data of Cerebral venous thrombosis with cytopenia, observed in Pfizer, Moderna, and AstraZeneca https://pubmed.ncbi.nlm.nih.gov/34375510/
A multicenter cohort study of cerebral venous thrombosis after AstraZeneca Vaccination: https://pubmed.ncbi.nlm.nih.gov/34370972/
45 cases of Cerebral Venous thrombosis: https://pubmed.ncbi.nlm.nih.gov/34288044/
International Cerebral Venous Thrombosis consortium report on cerebral venous thrombosis following vaccination against SARS-COV-2: https://pubmed.ncbi.nlm.nih.gov/34462996/
Fatal ICH following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34477089/
Treatment of AstraZeneca induced immume thrombotic thrombocytopenia related acute ischemic stroke: https://pubmed.ncbi.nlm.nih.gov/34461442/
Worsening Neuro-Oncologic Disease Symptoms following mRNA vaccination: https://www.cureus.com/articles/61880-new-onset-neurologic-symptoms-and-related-neuro-oncologic-lesions-discovered-after-covid-19-vaccination-two-neurosurgical-cases-and-review-of-post-vaccine-inflammatory-responses
Clinical characteristics of Headache following Pfizer, a multicenter observational cohort study: https://pubmed.ncbi.nlm.nih.gov/34405142/
Aseptic Meningitis following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34378098/
Delirium in an elderly patient following Pfizer: https://onlinelibrary.wiley.com/doi/10.1111/ggi.14163
Delirium in an elderly patient following vaccination: https://pubmed.ncbi.nlm.nih.gov/33829614/
Two cases of encephalopathy and seizures following Moderna: https://pubmed.ncbi.nlm.nih.gov/34367780/
Acute disseminated encephalitis following Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294707/
Acute Disseminated Encephalitis in a young female following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34480527/
Postvaccinal encephalitis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34324214/
Acute encephalitis, myoclonus, and sweet syndrome after mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34312136/
New onset psychosis in 31yoM after mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34388513/
Severe dyskinesia in Parkinson Patient following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34368991/
Cytotoxic lesion of the Corpus Callousum following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34402238/
Myeloperoxidase anti-neutrophil cytoplasmic antibody positive optic perineuritis after mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34432055/
Three cases: CVA, left facial nerve palsy, and myelitis all following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34507266/
Headache after AstraZeneca: a MultiCenter observational cohort center: https://pubmed.ncbi.nlm.nih.gov/34313952/
Characteristics of COVID vaccine induced Headache: https://pubmed.ncbi.nlm.nih.gov/34510919/
Covid Vaccines are not free of Neurologic side effects: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206845/
Rebuttal about Functional Neurologic Disorders and Vaccination: https://onlinelibrary.wiley.com/doi/full/10.1002/ana.26160?fbclid=IwAR3C-QQc-ZDEDoCu0fWNQuVYzvbC3qYHGekCaicU5-l_bOUz4N52jl1wjJ0
Neurologic safety monitoring of COVID-19 vaccines, lessons learned from the past to inform the present: https://pubmed.ncbi.nlm.nih.gov/34475124/
Cardiac:
Myocarditis in 23 military members: https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601
Perimyocarditis in teens: https://pubmed.ncbi.nlm.nih.gov/34077949/
Vaccination associated myocarditis in Adolescents: https://pubmed.ncbi.nlm.nih.gov/34389692/
mRNA vaccination and myocarditis in adolescents: https://pubmed.ncbi.nlm.nih.gov/34393110/
Association of myocarditis with mRNA vaccination, a case review in children: https://pubmed.ncbi.nlm.nih.gov/34374740/
Recurrence of myocarditis after vaccination: https://pubmed.ncbi.nlm.nih.gov/34166671/
Myopericarditis in young adults presenting to the ED: https://pubmed.ncbi.nlm.nih.gov/34310793/
Pericarditis following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34364831/
Myocarditis following J&J in a healthy, young male: https://pubmed.ncbi.nlm.nih.gov/34420869/
Acute myocarditis after Moderna in young male: https://pubmed.ncbi.nlm.nih.gov/34308326/
Myocarditis in a healthy male: https://pubmed.ncbi.nlm.nih.gov/34229940/
Acute myocarditis following vaccination: https://pubmed.ncbi.nlm.nih.gov/34331307/
Acute myocarditis following Pfizer in a healthy man with previous COVID infection: https://pubmed.ncbi.nlm.nih.gov/34367386/
Myocarditis case report: https://pubmed.ncbi.nlm.nih.gov/34118375/
Myocarditis following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34393273/
Myocarditis in 24yoM: https://pubmed.ncbi.nlm.nih.gov/34268277/
Myocarditis in a 24yoM nurse after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34400043/
Myocarditis in a 15yo following Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369878/
Myopericarditis in a 16yo following vaccination:
https://pubmed.ncbi.nlm.nih.gov/34133825/
Myocarditis in a 22yoM following Moderna: https://pubmed.ncbi.nlm.nih.gov/34348657/
70yoF with myocarditis following J&J Vaccination: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270733/
Biopsy proven lymphocytic myocarditis following 1st mRNA vaccination in a 40yo: https://pubmed.ncbi.nlm.nih.gov/34487236/
Cardiac imaging of acute myocarditis following mRNA in a 24yoM: https://pubmed.ncbi.nlm.nih.gov/34402228/
Cardiac MRI findings in young adults following mRNA vaccination: a case series: https://pubmed.ncbi.nlm.nih.gov/34496880/
Myopericarditis following mRNA vaccination: the role of cardiac biomarkers and multimodality imaging: https://pubmed.ncbi.nlm.nih.gov/34487161/
Myocarditis should be consider in those with a troponin rise and unobstructed arteries following Pfizer vaccination: https://pubmed.ncbi.nlm.nih.gov/34463755/
Myocarditis Associated with COVID-19 vaccination: echocardiography, cardiac tomography, and magnetic resonance imaging findings: https://pubmed.ncbi.nlm.nih.gov/34428917/
Fulminant myocarditis and systemic hyperinflammation in 2 patients following mRNA: https://pubmed.ncbi.nlm.nih.gov/34416319/
2 cases of histological confirmed myocarditis following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34407340/
Myocarditis and Pericarditis: 2 case reports: https://pubmed.ncbi.nlm.nih.gov/34277198/
Two cases of myocarditis:
https://pubmed.ncbi.nlm.nih.gov/34166884/
Two cases of myocarditis:
https://pubmed.ncbi.nlm.nih.gov/34166884/
3 cases of cardiac manifestation following Pfizer: https://academic.oup.com/qjmed/advance-article/doi/10.1093/qjmed/hcab177/6311674
4 cases of Myocarditis and their Cardiac MRI findings: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245050/
4 cases of myocarditis: https://pubmed.ncbi.nlm.nih.gov/34396358/
6 cases of men age 17-37 with myocarditis: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219373/
8 cases of myocarditis in adolescents following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34319393/
13 cases of Myocarditis in adolescents following Pfizer: https://www.jpeds.com/article/S0022-3476(21)00665-X/fulltext
Review of 15 published cases of myocarditis: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272967/
Review of 29 published cases of acute myopericarditis following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34356586/
Review of 214 myocarditis cases:: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233865/
JAMA article, concerns for perimyocarditis underreporting, review of 40 hospitals: https://jamanetwork.com/journals/jama/fullarticle/2782900
Intravenous injection of mRNA vaccine can induce acute myopericarditis in mouse model: https://pubmed.ncbi.nlm.nih.gov/34406358/
The Novel platform of mRNA vaccines and myocarditis: clues into the potential underlying mechanism: https://pubmed.ncbi.nlm.nih.gov/34312010/
3 cases of acute infarct-like myocarditis (2 Pfizer, 1 AstraZeneca): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325525/
2 cases of acute MI <24 hours after mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34364657/
Acute STEMI MI following AstraZeneca vaccination,?Kounis syndrome?: https://pubmed.ncbi.nlm.nih.gov/34394944/
Vaccine induced immune thrombocytopenia and thrombosis associated anterior ST-elevation myocardial infarction following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34486030/
Frequent PVS and NSVT following 2nd dose of Pfizer: https://pubmed.ncbi.nlm.nih.gov/34275963/
Isolated tachycardia in a 29yoF following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34466331/
Covid-19 vaccine associated Takotsubo cardiomyopathy: https://pubmed.ncbi.nlm.nih.gov/34375049/
63yoF with Takotsubo cardiomyopathy following Moderna: https://pubmed.ncbi.nlm.nih.gov/34330629/
Tachycardia following Pfizer: 3 cases in those previously infected with COVID-19: https://pubmed.ncbi.nlm.nih.gov/33858709/
Dizziness, HTN and new LBBB following AstraZeneca vaccination: https://pubmed.ncbi.nlm.nih.gov/34508485/
GI:
Gastroparesis following Pfizer: https://journals.lww.com/ajg/Citation/9900/Gastroparesis_After_Pfizer_BioNTech_COVID_19.28.aspx
Acute Necrotizing Pancreatitis following 2nd dose of Pfizer: https://pubmed.ncbi.nlm.nih.gov/34423463/
Acute Pancreatitis in a 96yoF following 1st dose of Pfizer: https://pubmed.ncbi.nlm.nih.gov/34084669/
Cutaneous hypersensitivity reaction with acute hepatitis following Pfizer 2nd dose: https://pubmed.ncbi.nlm.nih.gov/34485657/
41yo F with Autoimmune hepatitis following Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197609/
76yoF with autoimmune hepatitis following Moderna Vaccination: https://pubmed.ncbi.nlm.nih.gov/34332438/
71yoF with Autoimmune hepatitis after mRNA vaccine (Moderna): https://www.sciencedirect.com/science/article/pii/S0168827821018961?via%3Dihub
80yoF with autoimmune hepatitis following Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186938/
63yoM with autoimmune hepatitis following Moderna: https://pubmed.ncbi.nlm.nih.gov/34293683/
61yoF with liver injury following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34430106/
35yoF with autoimmune hepatitis following Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056822/
New Onset autoimmune hepatitis following mRNA vaccination in a 36yoF with Primary Sclerosing Cholangitis: https://pubmed.ncbi.nlm.nih.gov/34450237/
56yoF with autoimmune hepatitis following Moderna: https://www.journal-of-hepatology.eu/article/S0168-8278(21)00424-4/fulltext
Two cases of autoimmune hepatitis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34225251/
Liver injury in a liver transplant patient following mRNA vaccination: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214934/
16 cases of liver injury following Pfizer and Moderna: a multicenter case series: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324396/
Reactivation of Hepatitis C infection following Pfizer in a 82yoF: https://www.dovepress.com/hepatitis-c-virus-reactivation-following-covid-19-vaccination--a-case--peer-reviewed-fulltext-article-IMCRJ?fbclid=IwAR3u0x1baFcAZz1eOrNsXsgmrlUYt0EJV2SmoXA75RiplFQbPrtSAIo2GAs
Unusual fever, HA, and abdominal pain in a healthy woman following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34339677/
Hepatic vein thrombosis due to TTS following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34432063/
Renal:
ANCA glomerulonephritis after Moderna: https://www.kidney-international.org/article/S0085-2538(21)00555-X/fulltext
New onset ANCA vasculitis after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34280507/
ANCA associated Glomerulonephritis following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34423176/
Nephrotic Syndrome following AstraZeneca: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257404/
New onset Nephrotic syndrome following J&J: https://pubmed.ncbi.nlm.nih.gov/34342187/
Nephrotic syndrome and vasculitis following Pfizer, Moderna, and AstraZeneca: https://academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfab215/6318785
De novo vasculitis after Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166777/
ANCA associated vasculitis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34416184/
IgA and crescentic glomerulonephritis following Pfizer:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141343/
Minimal Change Disease Following Pfizer: https://pubmed.ncbi.nlm.nih.gov/33839200/
Minimal Change Disease relapse following Pfizer: https://www.ajkd.org/article/S0272-6386(21)00627-2/fulltext
MCD relapse following Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137360/
MCD relapse following Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098029/
Severe MCD relapse 3 days following Pfizer: https://europepmc.org/article/pmc/pmc8156905
Minimal change disease and AKI following Pfizer: https://www.kidney-international.org/article/S0085-2538(21)00493-2/pdf
Minimal Change disease following Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149162/
Minimal Change disease and Severe AKI following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34242687/
3 cases of minimal change disease following 2nd dose of mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34337193/
IgA nephropathy in 2 pediatric patients after Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256683/
3 cases of IgA nephropathy patients developing exacerbations following mRNA vaccine: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166778/
2 cases of IgA nephropathy patients developing exacerbations following moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987498/
IgA nephropathy flare up following Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079938/
IgA Nephropathy after mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34278290/
2 cases of IgA Nephropathy patients developing hematuria after Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329426/
Reactivation of IgA vasculitis following Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260100/
IgA vasculitis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34509658/
IgA nephropathy flare-up following vaccination: https://pubmed.ncbi.nlm.nih.gov/34415336/
Membranous nephropathy following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34419553/
Membranous nephropathy following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34332960/
Renal Thrombotic Microangiopathy following Pfizer in a 35yoM: https://pubmed.ncbi.nlm.nih.gov/34451509/
Rheumatology/Endocrinology/Orthopedics:
Lupus exacerbation: https://onlinelibrary.wiley.com/doi/10.1111/dth.15017
Lupus exacerbation following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34291477/
Systemic lupus following vaccination: https://pubmed.ncbi.nlm.nih.gov/34418261/
Relapse of class V lupus. Nephritis after mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34352310/
Subacute cutaneous lupus erythematosus flare triggered by Moderna: https://pubmed.ncbi.nlm.nih.gov/34455671/
Emergence of new onset SLE following vaccination: https://pubmed.ncbi.nlm.nih.gov/34450645/
Hyperglycemic crisis: https://onlinelibrary.wiley.com/doi/abs/10.1111/dme.14631
Perturbation of blood glucose following vaccination, a review of 20 adults: https://pubmed.ncbi.nlm.nih.gov/34375490/
Subacute Thyroiditis: https://www.tandfonline.com/doi/abs/10.1080/21645515.2021.1947102?fbclid=IwAR02FYW94iQGbu6e2uTpD42XoIwp6QHzwhDBWotULtT4ZCGR5sVKkyexbRg
Two cases of subacute thyroiditis after Moderna and AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34504856/
Two cases of Graves disease following vaccination: https://pubmed.ncbi.nlm.nih.gov/33858208/
Two more cases of Graves disease following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34342859/
5 cases of adrenal crisis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34358373/
Myositis in a 56yoF following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/33647971/
mRNA induced rhabdomyolysis and fasciitis: https://pubmed.ncbi.nlm.nih.gov/34435250/
Rhabdomyolysis after Moderna: https://pubmed.ncbi.nlm.nih.gov/34150372/
21yoM with Pfizer induced rhabdomyolysis: https://pubmed.ncbi.nlm.nih.gov/34186348/
Quadrilateral space region inflammation and other incidental findings on shoulder MRI following Pfizer COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34306275/
Rash, arthritis, swelling, muscle weakness following AstraZeneca: https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.27175
Polyarthralgia and Myalgia syndrome after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34463066/
40yoF with Henoch-Schonlein Purpura following Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241653/
New onset mainly guttate psoriasis after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34309932/
2 cases of exacerbation of plaque psoriasis after Pfizer and CoronaVac: https://pubmed.ncbi.nlm.nih.gov/34427024/
14 cases of psoriasis activation following vaccination (Moderna, Pfizer, and AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34363647/
Pustuluar psoriasis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34398977/
Psorasis exacerbation after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34487570/
Arthritis in the L elbow following vaccination: https://pubmed.ncbi.nlm.nih.gov/34363344/
Vasculitis and bursitis on 18F FDG-PET/CT following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34495381/
Remitting seronegative symmetrical synovitis with pitting edema following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34348912/
Scleroderma renal crisis following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34339745/
Adult onset Still’s disease following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34316728/
Adult onset Still’s disease following mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34316726/
Hyper-inflammation after COVID-19 mRNA vaccination: at the cross roads of multi-inflammatory disease and adult onset still’s disease:
https://pubmed.ncbi.nlm.nih.gov/34487678/
Immune mediated disease flares: https://pubmed.ncbi.nlm.nih.gov/33946748/
Local and systemic reactogenicity of Pfizer in patients with systemic lupus and rheumatoid arthritis: https://pubmed.ncbi.nlm.nih.gov/34476603/
Incidence of disease flare after Pfizer vaccination in patients with rheumatoid arthritis in remission: https://pubmed.ncbi.nlm.nih.gov/34472714/
11% of patients with rheumatic and MSK diseases report disease flare following 2 dose mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34346185/
Hematology
Superior ophthalmic Vein Thrombosis and Thrombocytopenia following AstraZeneca: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265377/
Autoimmune hemolytic anemia: https://pubmed.ncbi.nlm.nih.gov/34150386/
Autoimmine hemolytic anemia following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34258873/
ITP and AIHA following Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274740/
ITP Exacerbation in 12% of chronic patients: https://pubmed.ncbi.nlm.nih.gov/34075578/
ITP Exacerbation in previous stable patient following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34307734/
ITP following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34155844/
ITP following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34382388/
Secondary ITP and resulting hemorrhage and hematoma after minor oral surgery after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34314875/
ITP and diffuse papular rash following Moderna: https://www.scienceopen.com/document_file/691feaa0-8e64-40c4-9553-40382bd5ac48/PubMedCentral/691feaa0-8e64-40c4-9553-40382bd5ac48.pdf
ITP following Astrazeneca: https://ashpublications.org/blood/article/doi/10.1182/blood.2021012790/476455/Immune-Thrombocytopenic-Purpura-after-vaccination
ITP in 1st trimester of pregnancy 13 days following vaccination in the US: https://pubmed.ncbi.nlm.nih.gov/34420249/
84yoM with ITP following Pfizer: https://link.springer.com/article/10.1007/s11739-021-02778-w
41yoF with ITP following Pfizer: https://casereports.bmj.com/content/14/5/e242220
69yoF with refractory ITP following Pfizer: https://journals.lww.com/americantherapeutics/Citation/2021/08000/Immune_Thrombocytopenic_Purpura_Associated_With.24.aspx
20yoF with ITP following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34381692/
54yoF with ITP following Pfizer: https://www.cureus.com/articles/56899-newly-diagnosed-idiopathic-thrombocytopenia-post-covid-19-vaccine-administration
74yoM with ITP following Moderna: https://www.dovepress.com/severe-refractory-immune-thrombocytopenia-occurring-after-sars-cov-2-v-peer-reviewed-fulltext-article-JBM
26yoF with ITP and acute liver injury following Moderna: https://pubmed.ncbi.nlm.nih.gov/34330722/
26yoF with ITP following Moderna: http://pubs.sciepub.com/ajmcr/9/8/3/index.html
63yoF with ITP following Johnson and Johnson: https://pubmed.ncbi.nlm.nih.gov/34469919/
68yoF with ITP following Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385179/
86yoM with ITP following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34446449/
41yoM with ITP following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34377889/
3 cases of ITP following Pfizer and Astra Zeneca: https://www.mjhid.org/index.php/mjhid/article/view/4669/4043
3 cases reports of ITP following Pfizer and J&J: https://ehoonline.biomedcentral.com/articles/10.1186/s40164-021-00235-0
3 cases: recurrent AvWD and acquired hemophilia A after Moderna, PNH flare following Moderna, and ITP flare following Moderna: https://ashpublications.org/bloodadvances/article/5/13/2794/476324/Autoimmune-and-complement-mediated-hematologic
3 cases of ITP in elderly patients following vaccination: https://www.hindawi.com/journals/crihem/2016/7913092/
36 Cases of ITP following Pfizer and Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011062/
PE, TIA, and thrombocytopenia after J&J: https://pubmed.ncbi.nlm.nih.gov/34261635/
DVT and PE and positive HIT panel following mRNA Vaccine: https://pubmed.ncbi.nlm.nih.gov/34117206/
3 patients with venous thromboembolism following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34352418/
Thrombosis with Thrombocytopenia following Moderna: https://www.acpjournals.org/doi/full/10.7326/L21-0244
TTP Following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34264514/
Acquired TTP following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34309715/
TTP in an adolescent following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34405400/
Thrombocytopenia in a teen with sickle cell disease following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34331506/
Safety warning for AstraZeneca in patients with sickle cell disease: https://mjhid.org/index.php/mjhid/article/view/4708?fbclid=IwAR2kMtsqqwiYyxxQ9XxIvDFdOSt-yTPqjAro-fgaEp460JeHd0QwBxx4DPg
5 cases of prothrombotic immune thrombocytopenia after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34323939/
20 cases of Thrombocytopenia following Pfizer and Moderna: https://onlinelibrary.wiley.com/doi/10.1002/ajh.26132
Review of 50 cases of thrombocytopenia following Astrazeneca, Pfizer, Moderna: https://pubmed.ncbi.nlm.nih.gov/34332437/
68yoF with extensive thrombosis after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34400433/
Thrombotic Thrombocytopenia after AstraZeneca: Autopsy findings: https://pubmed.ncbi.nlm.nih.gov/34355379/
Fatal ICH due to Thrombotic Thrombocytopenia following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34402235/
Five cases with a combination of cerebral venous thrombosis, intracerebral hemorrhage and thrombocytopenia following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34393988/
Confusion and abdominal pain due to VITT following vaccination: https://pubmed.ncbi.nlm.nih.gov/34346657/
Fatal thromboembolism in a patient with preexisting thrombocytopenia following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34344867/
Malignant CVA due to VITT following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34341358/
3 cases of immune thrombocytopenia following AstraZeneca in Thailand: https://pubmed.ncbi.nlm.nih.gov/34483267/
Treatment Guide to Thrombotic Thrombocytopenia Following Vaccination: https://www.hematology.org/covid-19/vaccine-induced-immune-thrombotic-thrombocytopenia
Successful venous thromboprophylaxis in a patient with AstraZeneca induced VITT: https://pubmed.ncbi.nlm.nih.gov/34496889/
Autoimmunity roots of the thrombotic events following COVID vaccination: https://pubmed.ncbi.nlm.nih.gov/34508917/
Thrombosis post COVID-19 vaccinations: Potential link to ACE pathways: https://pubmed.ncbi.nlm.nih.gov/34479129/
Platelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34474550/
The known knowns and known unknowns of vaccine-induced thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34472568/
Skin, nose, and gingival bleeding episodes after AstraZeneca: a large population-based cohort study: https://pubmed.ncbi.nlm.nih.gov/34479760/
Haemophagocytosis and atypical lymphocytes on bone marrow biopsy following vaccination: https://pubmed.ncbi.nlm.nih.gov/34312842/
3 cases of HLH following AstraZeneca: https://jcp.bmj.com/content/early/2021/07/22/jclinpath-2021-207760
Coagulopathies after vaccination against SARS-COV-2 may be derived from a combo of spike protein and adenovirus vector-triggered signaling pathways: https://arxiv.org/abs/2109.00089?fbclid=IwAR2orycgbxqSNXLR9A4XjNwEAZBumiRbRKsfW8KL5qiJCXSWwqmLiMtc4Z4
The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34455073/
Oncology
Axillary lymphadenopathy following mRNA vaccination:
https://pubmed.ncbi.nlm.nih.gov/34156552/
Ipsilateral axillary adenopathy following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34333959/
4 cases of axillary adenopathy following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34303188/
Axillary adenopathy following AstraZeneca resulting in possible misinterpretation of PET scan in metastatic melanoma patient: https://pubmed.ncbi.nlm.nih.gov/34414110/
163 cases of axillary adenopathy following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34257025/
Incidence of axillary adenopathy on Breast Imaging following Vaccination: https://pubmed.ncbi.nlm.nih.gov/34292295/
Supraclavicular lymphadenopathy following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34414929/
Cervical lymphadenopathy following Pfizer:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204135/
13 cases of Cervical lymphadenopathy: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241354/
50yoM with adenopathy following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34406229/
Review of 24 cases of lymphadenopathy and their ultrasound findings in the US: https://pubmed.ncbi.nlm.nih.gov/34356507/
Kikucki-Fujimoto disease following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34395192/
Mammographic and sonographic findings in the breast and axillary tail following vaccination: https://pubmed.ncbi.nlm.nih.gov/34340203/
Vaccine related unilateral axillary lymphadenopathy:pattern on screening breast MRI: https://pubmed.ncbi.nlm.nih.gov/34325221/
Evolution of lymphadenopathy at PET/MRI after vaccination: https://pubmed.ncbi.nlm.nih.gov/34310229/
Axillary lymphadenopathy after COVID vaccination in patients with thoracic malignancy: https://pubmed.ncbi.nlm.nih.gov/34506955/
DOTATATE PET-avid axillary lymph node after injection of the Johnson & Johnson: https://pubmed.ncbi.nlm.nih.gov/34269723/
DOTATOC-avid lymphadenopathies induced by mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34363083/
3 cases of supraclavicular and axillary lymphadenopathy induced by vaccination on 18F-Fluorthanatrace, 68Ga-DOTATATE, and 18F-Fluciclovine PET/CT: https://pubmed.ncbi.nlm.nih.gov/34507331/
FDG uptake in axillary lymph nodes after vaccination: a pitfall case of highly suspicious lymph nodes metastases of malignant melanoma: https://pubmed.ncbi.nlm.nih.gov/34412144/
Avid left axillary nodes and intense diffuse splenic uptake and moderate diffuse bone marrow uptake on PET 1 week after vaccination: https://pubmed.ncbi.nlm.nih.gov/34269722/
Vaccination effect on tracer uptake with FDG-PET/CT: https://pubmed.ncbi.nlm.nih.gov/34297113/
Abnormal PET following vaccination: https://onlinelibrary.wiley.com/doi/full/10.1002/pbc.29262
Positive PET following vaccination: https://pubmed.ncbi.nlm.nih.gov/34301777/
False Positive FDG PET CT after vaccination in a woman treated for metastatic breast cancer: https://pubmed.ncbi.nlm.nih.gov/34308402/
The day after mass COVID vaccination: higher hypermetabolic lymphadenopathy detection on PET/CT and impact on oncologic management: https://pubmed.ncbi.nlm.nih.gov/34503150/
Temporal metabolic response to mRNA vaccinations in oncology patients: https://pubmed.ncbi.nlm.nih.gov/34463888/
Thymic hyperplasia after mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34462647/
Fatal systemic capillary leak syndrome after Johnson and Johnson vaccination in a multiple myeloma patient: https://pubmed.ncbi.nlm.nih.gov/34459725/
Moderna vaccination mimicking lymph-node progression in a patient with melanoma: https://pubmed.ncbi.nlm.nih.gov/34433198/
Post vaccination lymphadenopathy: report of cytological findings from fine needle aspiration biopsy: https://pubmed.ncbi.nlm.nih.gov/34432391/
Rituximab-induced acute lympholysis and pancytopenia after Moderna in a 71yoM with b-cell lymphoplasmacytic lymphoma: https://pubmed.ncbi.nlm.nih.gov/34429981/
Dermatology/Plastics:
60yo with Steven Johnson Syndrome: https://pubmed.ncbi.nlm.nih.gov/34081806/
Steven Johnson Syndrome following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34384729/
Pemphigus Vulgaris:
https://pubmed.ncbi.nlm.nih.gov/34169588/
Morbilliform Rash:
https://pubmed.ncbi.nlm.nih.gov/34167874/
Pityriasis-rosea like eruption post-vaccination in a young male: https://pubmed.ncbi.nlm.nih.gov/34165237/
Pityriasis rosea following Pfizer: https://onlinelibrary.wiley.com/doi/10.1111/jdv.17498
66yoM with Pityriasis rosea after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34435935/
1 case of Pityriasis rosea and 3 cases of urticaria following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34478204/
A case series of Pityriasis rosea following vaccination: https://pubmed.ncbi.nlm.nih.gov/34363731/
Two cases of papulo-pustular rosacea-like eruptions following Pfizer and AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34416044/
Pityriasis rubra pilaris following Astra Zeneca: https://pubmed.ncbi.nlm.nih.gov/34310778/
Pityriasis rubra pilaris in 72yoM following Astra Zeneca: https://pubmed.ncbi.nlm.nih.gov/34420983/
Pityriasis Rubra Pilaris like eruption following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34379821/
3 cases of new onset acral hand lesions following mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34310777/
2 patients with eczematous cutaneous reactions following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34236729/
New onset synovitis and palmoplantar psoriasis flare up after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34236728/
Exacerbation of Hailey-Hailey Disease following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34436620/
New onset lichen planus following Pfizer: https://onlinelibrary.wiley.com/doi/10.1111/jdv.17504
Lichen striatus: https://pubmed.ncbi.nlm.nih.gov/34423105/
Purpura annularis telangiectodes following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34236717/
Flagellate Purpura following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34416052/
Symmetrical drug related intertriginous and flexural exanthema like eruption following AztraZeneca: https://pubmed.ncbi.nlm.nih.gov/34399001/
Vitiligo following Pfizer: https://onlinelibrary.wiley.com/doi/10.1111/ced.14842
Vitiligo in a Ulcerative Colitis Patient following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34498300/
Bacillus Calmette-Guerin scar flare after mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34344774/
Palms and Soles Itchiness following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34391695/
Resistant pruritis skin rash following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34358176/
Necrotic eschars at injection sites one week after 2nd dose of Pfizer: https://pubmed.ncbi.nlm.nih.gov/34337117/
Facial Pustular Neutrophilic Eruption following mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34319363/
Acute generalized exanthematous pustulosis induced by Moderna: https://pubmed.ncbi.nlm.nih.gov/34466640/
AstraZeneca induced acute localized exanthematous pustulosis: https://pubmed.ncbi.nlm.nih.gov/34487574/
Delayed local skin reactions: https://www.nejm.org/doi/full/10.1056/NEJMc2102131?fbclid=IwAR0P6wjXiO4swT4wz0lEJCBx7v14e2Si-O9AbOuhlVisVHFhc_kGEy7pyj0
Delayed skin reactions following mRNA vaccine: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288253/
11 patients with delayed skin reaction after mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34433495/
Additional 12 Patients with Delayed Local Reactions: https://www.nejm.org/doi/full/10.1056/NEJMc2102131
16 patients delayed hypersensitivity reactions after Moderna: https://jamanetwork.com/journals/jamadermatology/fullarticle/2779643
138 Delayed Hypersensitivity Reactions following vaccination: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294276/
Delayed local Hypersensitivity reactions: a 6 month retrospective study: https://pubmed.ncbi.nlm.nih.gov/34288056/
Delayed cutaneous hypersensitivity reaction following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34351606/
Cutaneous skin manifestation following Moderna with Hypersensitivity reaction Histopathology: https://pubmed.ncbi.nlm.nih.gov/34414254/
2 cases of delayed local reactions following Moderna: https://journals.lww.com/infectdis/Fulltext/2021/07000/Delayed_Skin_Rash_After_Receiving_SARS_CoV_2_mRNA.19.aspx
4 cases of cutaneous hypersensitivity reactions following Moderna: https://pubmed.ncbi.nlm.nih.gov/34485656/
5 Japanese cases of delayed large local reactions to Pfizer vaccination: https://pubmed.ncbi.nlm.nih.gov/34459023/
13 cases delayed local reactions following mRNA vaccine: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab518/6291929
COVID Vaccine arm: https://www.psychologytoday.com/us/blog/heal-the-mind-heal-the-body/202101/what-s-the-new-phenomenon-called-covid-vaccine-arm
COVID arm following Moderna: histologic features: https://pubmed.ncbi.nlm.nih.gov/34242422/
Covid vaccine arm may present after both mRNA vaccines vaccination: https://pubmed.ncbi.nlm.nih.gov/34416053/
405 cases of dermatologic reactions following Pfizer, Moderna, and Astra Zeneca: https://pubmed.ncbi.nlm.nih.gov/34254291/
Erythema Migrans like rash after Moderna: https://pubmed.ncbi.nlm.nih.gov/34250736/
Bullous Drug Eruption Rash following Moderna: https://pubmed.ncbi.nlm.nih.gov/34294590/
Bullous eruption following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34416058/
Bullous Fixed Drug Eruption following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34482558/
Atypical erythema multiforme related to Pfizer vaccine: https://pubmed.ncbi.nlm.nih.gov/34473839/
Soft Tissue Filler Inflammatory Reaction after vaccination:
https://pubmed.ncbi.nlm.nih.gov/34174156/
Immune Response to fillers and breast implants after vaccination: https://pubmed.ncbi.nlm.nih.gov/34174765/
Breast Implant seroma after mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34405902/
L Breast Implant Capsular Contracture following Moderna vaccination: https://pubmed.ncbi.nlm.nih.gov/34373851/
COVID-toes after mRNA vaccination:
https://pubmed.ncbi.nlm.nih.gov/34162525/
Leukoclastic vasculitis: https://onlinelibrary.wiley.com/doi/abs/10.1002/art.41910
Urticarial Vasculitis following vaccination: https://journals.lww.com/amjdermatopathology/Citation/9000/Unique_Case_of_Urticarial_Skin_Eruptions_After.97698.aspx
Urticarial Vasculitis: https://pubmed.ncbi.nlm.nih.gov/34369046/
Small vessel vasculitis after Astra Zeneca: https://pubmed.ncbi.nlm.nih.gov/34310763/
Cutaneous small vessel vasculitis following J&J: https://pubmed.ncbi.nlm.nih.gov/34337124/
Cutaneous lymphocytic vasculitis following mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34327795/
Pfizer induced reactivation of varicella and resulting small vessel vasculitis: https://pubmed.ncbi.nlm.nih.gov/34310759/
2 cases of skin color discoloration following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34310755/
A case series of rare cutaneous adverse events following vaccination: https://pubmed.ncbi.nlm.nih.gov/34363637/
Moderna Vaccine Induced Skin Rash: https://pubmed.ncbi.nlm.nih.gov/34423142/
A Case series of Cutaneous vaccine reactions at Loma Linda University: https://pubmed.ncbi.nlm.nih.gov/34423106/
Clinicopathological features of cutaneous reactions after mRNA vaccines, 11 cases: https://pubmed.ncbi.nlm.nih.gov/34459036/
3 cases of vesiculobullous non-IgE-mediated cutaneous reactions to Pfizer: https://pubmed.ncbi.nlm.nih.gov/34363258/
A narrative review of cutaneous and hypersensitivity reactions: https://pubmed.ncbi.nlm.nih.gov/34424434/
SARS-CoV-2 Vaccines and the Skin: https://pubmed.ncbi.nlm.nih.gov/34483343/
Ophthalmology:
Acute Macular Neuroretinopathy after AstraZeneca:
https://www.nature.com/articles/s41433-021-01610-1.epdf...
Acute macular neuroretinopathy following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34485760/
Acute Central Serous Retinopathy after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34151047/
Panuveitis: https://pubmed.ncbi.nlm.nih.gov/34213988/
Reduction of Visual Acuity following Pfizer: https://link.springer.com/article/10.1007/s00011-021-01476-9?fbclid=IwAR3zAvenOwPAZmuVsx9CM7bFwOliHerfJK3M3nQCMe-3BWoT4QdNCWK7cNo
Corneal graft rejection after Pfizer vaccination: https://pubmed.ncbi.nlm.nih.gov/34426655/
Bilateral Retinal Detachments 10 days after mRNA vaccination 22yoF : https://www.jem-journal.com/article/S0736-4679(21)00611-9/fulltext
Central Retinal Vein Occlusion occuing immediately after 2nd dose of mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34426861/
Transient Oculomotor palsy following mRNA. Vaccine: https://pubmed.ncbi.nlm.nih.gov/34369471/
Anterior Uveitis following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34289406/
21 cases of Uveitis following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34369440/
A case of bilateral arteritic anterior ischemic optic neuropathy and a case of bilateral acute zonal occult outer retinopathy after mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34394876/
Vaccination and Bilateral Multifocal Choroiditis: https://pubmed.ncbi.nlm.nih.gov/34406890/
34yoM with bilateral multifocal choroiditis following 2nd dose vaccination: https://pubmed.ncbi.nlm.nih.gov/34344280/
Acute painless bilateral blurring of vision following Pfizer due to Vogt-Koyanagi-Hara disease: https://pubmed.ncbi.nlm.nih.gov/34505819/
Eyelid erythema after Pfizer vaccination: https://pubmed.ncbi.nlm.nih.gov/34426009/
Reactivation of herpes simplex keratitis following AstraZeneca vaccination: https://pubmed.ncbi.nlm.nih.gov/34493563/
2 cases of Ipsilateral zoster opthalmicus after Moderna and Johnson and Johnson: https://pubmed.ncbi.nlm.nih.gov/34471577/
Bilateral immune mediated keratolysis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34483273/
COVID-19, COVID-19 vaccinations, and subsequent abnormalities in the retina: causation or coincidence? https://pubmed.ncbi.nlm.nih.gov/34473193/
ENT
3 cases of Tinnitus following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34120553/
18 cases of idiopathic sensorineural hearing loss, tinnitus, and/or vertigo following Moderna/Pfizer: https://pubmed.ncbi.nlm.nih.gov/34267103/
Tinnitus/cochleopathy following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34297133/
Lipschutz ulcers after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34366434/
ID
Herpes Zoster following Moderna: https://pubmed.ncbi.nlm.nih.gov/34397201/
Herpes Zoster reactivation following Moderna: https://pubmed.ncbi.nlm.nih.gov/34316506/
Ramsy Hunt syndrome following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34344559/
A case series of Herpes Zoster following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34363717/
2 cases of herpes zoster following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34428545/
2 cases of herpes zoster in healthy young adults following vaccination: https://pubmed.ncbi.nlm.nih.gov/34363257/
3 cases of Herpes Zoster following Vaccination (Moderna and AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34293165/
3 cases of Herpes Zoster after covid vaccination in patients with chronic urticaria being treated with cyclosporine: https://pubmed.ncbi.nlm.nih.gov/34510694/
4 cases of Herpes Zoster (2 pfizer, 2 astrazeneca): https://pubmed.ncbi.nlm.nih.gov/34310754/
6 cases of Herpes Zoster following Pfizer: https://pubmed.ncbi.nlm.nih.gov/33848321/
A case of varicella-zoster virus after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34390376/
Varicella zoster reactivation and mRNA vaccines as a trigger: https://pubmed.ncbi.nlm.nih.gov/34316507/
40 cases of HSV and VZV reactivation following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34487581/
Miscellaneous:
Multisystem inflammatory syndrome in an adult following Pfizer (MIS-V): https://pubmed.ncbi.nlm.nih.gov/34326117/
3 cases of Multisystem Inflammatory Syndrome after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34034858/
Hypertension following mRNA vaccination:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206586/
POTS following Pfizer: https://www.cureus.com/articles/56242-a-case-of-postural-orthostatic-tachycardia-syndrome-secondary-to-the-messenger-rna-covid-19-vaccine
Vaccine induced interstitial lung disease in 86yoM after mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34362838/
Vaccine induced interstitial lung disease: https://pubmed.ncbi.nlm.nih.gov/34510014/
Pulmonary Embolus following Moderna: https://pubmed.ncbi.nlm.nih.gov/34452028/
Concerns for Pfizer vaccine failure to wildtype variants after Delta and vaccine induced enhanced illness, as demonstrated in a mice model: https://www.biorxiv.org/content/10.1101/2021.08.22.457114v1.full.pdf
International call for vaccine adverse reaction investigation: https://www.researchgate.net/publication/351670290_SARS-CoV-2_mass_vaccination_Urgent_questions_on_vaccine_safety_that_demand_answers_from_international_health_agencies_regulatory_authorities_governments_and_vaccine_developers?fbclid=IwAR1Gwfel6khY8ObziHNTGZriwS0Gez0CCp8zjaHllCJ9lfceD2EkJdMKmYw
Concerns about the lipid nanoparticle in the mRNA contributing to adverse reactions: https://www.biorxiv.org/content/10.1101/2021.03.04.430128v1.full?fbclid=IwAR2yUJH9kAb01O2PJ46AfBvQANuGiQvZd3ROs4R8qNJF6CZ4f255hDdRsSY
Medscape Health Care Professional Adverse Reactions: https://www.medscape.com/sites/public/covid-19/vaccine-insights/how-concerned-are-you-about-vaccine-related-adverse-events?src=soc_fb_share&fbclid=IwAR1zS9dnzVFRxBghSFv3hjdtinVxBkQJiopbY4fbFCKvyEgsw9TXokQ7b0I
Facebook link to reactions: https://www.facebook.com/profile.php?id=100068922816380